Drugs / ADXS31-142
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02325557 | Jun 2015 → Aug 2019 | prostate cancer | Advaxis, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ADXS31-142 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02325557 ↗ |
| Route | Intravenous | “ADXS31-142 IV infusion” NCT02325557 ↗ |